CR20200056A - Novedosos compuestos que activan la ruta nrf2 - Google Patents

Novedosos compuestos que activan la ruta nrf2

Info

Publication number
CR20200056A
CR20200056A CR20200056A CR20200056A CR20200056A CR 20200056 A CR20200056 A CR 20200056A CR 20200056 A CR20200056 A CR 20200056A CR 20200056 A CR20200056 A CR 20200056A CR 20200056 A CR20200056 A CR 20200056A
Authority
CR
Costa Rica
Prior art keywords
novel compounds
nrf2 pathway
compounds activating
activating
compounds
Prior art date
Application number
CR20200056A
Other languages
English (en)
Inventor
Duran Carlos Puig
Casals Laia Miret
Stephen Fiacco
Andrew Davis
Canela Nuria Trallero
Paniagua Carlos Heras
Benitez Miriam Gongora
Tomillero Ivan Ramos
Stefan Geschwindner
Palomera Fernando Albericio
Bas Marta Paradis
Cubero Omar Brun
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of CR20200056A publication Critical patent/CR20200056A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a compuestos peptídicos, cuyos compuestos peptídicos son compuestos de fórmula (I)¿, o una sal, o solvato, o N-óxido, o estereoisómero farmacéuticamente aceptable del mismo: Fórmula (I)¿ en la que R1; R2; s; t; u; Aa78 y G1 son como se han definido en el presente documento. Los compuestos peptídicos son útiles para activar la ruta Nrf2.
CR20200056A 2017-08-08 2018-08-08 Novedosos compuestos que activan la ruta nrf2 CR20200056A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382558 2017-08-08
PCT/EP2018/071536 WO2019030298A1 (en) 2017-08-08 2018-08-08 NEW COMPOUNDS THAT ACTIVATE THE NRF2 PATH

Publications (1)

Publication Number Publication Date
CR20200056A true CR20200056A (es) 2020-03-16

Family

ID=59677167

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20200056A CR20200056A (es) 2017-08-08 2018-08-08 Novedosos compuestos que activan la ruta nrf2

Country Status (24)

Country Link
US (1) US20200255478A1 (es)
EP (1) EP3665182A1 (es)
JP (1) JP2020530022A (es)
KR (1) KR20200035269A (es)
CN (1) CN110997695A (es)
AR (1) AR113100A1 (es)
AU (1) AU2018314833B2 (es)
BR (1) BR112019026306A2 (es)
CA (1) CA3066698A1 (es)
CL (1) CL2020000305A1 (es)
CO (1) CO2020000617A2 (es)
CR (1) CR20200056A (es)
DO (1) DOP2020000017A (es)
EA (1) EA202090432A1 (es)
EC (1) ECSP20008530A (es)
IL (1) IL272467A (es)
JO (1) JOP20200025A1 (es)
MA (1) MA49828A (es)
MX (1) MX2020001481A (es)
PE (1) PE20211460A1 (es)
PH (1) PH12019502852A1 (es)
SG (1) SG11201913161WA (es)
TW (1) TW201919682A (es)
WO (1) WO2019030298A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR128023A1 (es) * 2021-12-17 2024-03-20 3B Pharmaceuticals Gmbh Ligandos de anhidrasa carbónica ix

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992003175A1 (en) 1990-08-11 1992-03-05 Fisons Plc Inhalation device
DE4027391A1 (de) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
DE69132850T2 (de) 1990-09-26 2002-05-29 Pharmachemie Bv Wirbelkammer-Pulverinhalator
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
WO1994014492A2 (en) 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
RO119116B1 (ro) 1995-04-14 2004-04-30 Glaxo Wellcome Inc. Inhalator pentru dozarea salmeterolului
NZ502870A (en) 1995-06-21 2001-06-29 Asta Medica Ag Inhaler for powdered medicaments comprising a visual display device to indicate the discharge status of the inhaler
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
ES2351976T3 (es) 2003-04-29 2011-02-14 Avi Biopharma, Inc. Composiciones para mejorar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células.
DE602005023690D1 (de) 2004-07-16 2010-11-04 Almirall Sa Inhalator für die Abgabe von pharmzeutischen Pulver, und ein Pulverkassette zur Verwendung mit diesem Inhalator
CA2676933C (en) 2007-02-28 2015-09-29 Leo Pharma A/S Novel phosphodiesterase inhibitors
JP2011523557A (ja) 2008-06-04 2011-08-18 メディカル リサーチ カウンシル ペプチド
JP2012051826A (ja) * 2010-08-31 2012-03-15 Toray Ind Inc 環状ペプチド及びその修飾ペプチド並びにＫｅｌｃｈ様ＥＣＨ結合タンパク質１の結合阻害物質のスクリーニング方法
KR102339196B1 (ko) 2011-05-05 2021-12-15 사렙타 쎄러퓨틱스, 인코퍼레이티드 펩타이드 올리고뉴클레오타이드 접합체
JP6077543B2 (ja) 2011-08-30 2017-02-08 メディカル リサーチ カウンシルＭｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ Ｃｏｕｎｃｉｌ ペプチド
JP2015067579A (ja) * 2013-09-30 2015-04-13 国立大学法人東北大学 細胞透過性ペプチド及び当該ペプチドを含む医薬組成物。

Also Published As

Publication number Publication date
BR112019026306A2 (pt) 2020-07-14
EA202090432A1 (ru) 2020-06-08
CA3066698A1 (en) 2019-02-14
AU2018314833A1 (en) 2020-01-02
CO2020000617A2 (es) 2020-05-05
CL2020000305A1 (es) 2020-06-26
TW201919682A (zh) 2019-06-01
MA49828A (fr) 2020-06-17
MX2020001481A (es) 2020-03-20
DOP2020000017A (es) 2020-02-28
IL272467A (en) 2020-03-31
EP3665182A1 (en) 2020-06-17
JOP20200025A1 (ar) 2020-02-04
AR113100A1 (es) 2020-01-29
CN110997695A (zh) 2020-04-10
US20200255478A1 (en) 2020-08-13
PH12019502852A1 (en) 2020-09-28
JP2020530022A (ja) 2020-10-15
AU2018314833B2 (en) 2020-03-19
ECSP20008530A (es) 2020-05-29
SG11201913161WA (en) 2020-01-30
KR20200035269A (ko) 2020-04-02
PE20211460A1 (es) 2021-08-05
WO2019030298A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
PH12016501813A1 (en) 1,3-benzodioxole derivative
JOP20180113A1 (ar) مركبات ,تركيبات وطرق
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
SG10201811384TA (en) Mnk inhibitors and methods related thereto
SG10201811204RA (en) Bicyclic heterocyclyl derivatives as irak4 inhibitors
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
MA39956A (fr) Analogues du benzomorphane et leur utilisation
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MY192425A (en) Polymorphs
WO2016040952A3 (en) BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS
PH12018500377A1 (en) Novel annelated benzamides
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
SA518390920B1 (ar) مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة
WO2017011340A3 (en) Proteins and immunizing compositions containing klebsiella proteins and methods of use
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
MX2020011986A (es) Composiciones que comprenden glucosa y hemicelulosa y su uso.
TN2017000342A1 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
MX2019006768A (es) Peptidos antimicrobianos.
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
WO2018125880A8 (en) Nrf2 activator
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
PH12019502852A1 (en) Novel compounds activating the nrf2 pathway
GB201915828D0 (en) Compounds, compositions and therapeutic uses thereof
MX2017013694A (es) Derivados de aminohidrotiazina fusionados con tetrahidrofurano los cuales son utiles en el tratamiento de la enfermedad de alzheimer.